MedTrace Logo

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

NCT00304434 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2009-09-23

No results posted yet for this study

Summary

Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.

Conditions

Interventions

DRUG

Oseltamivir

DRUG

Probenecid

Sponsors & Collaborators

Principal Investigators

  • Mark Holodniy, MD · VA Palo Alto Health Care System

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304434 on ClinicalTrials.gov